Considering that many patients are Medicare beneficiaries, expensive drugs are devouring federal health care dollars, often for only minimal survival gains.As Meropol describes, the U.

• 许多病患是医疗保险的受益人，但昂贵的药物吞食了联邦医疗保健经费，而且经常只是为了极少的存活时间或存活率。